IP68-26: Incorporating PSMA PET/CT Parameters into Clinicopathologic Nomograms for Predicting Lymph Node Involvement in Intermediate- and High-Risk Prostate Cancer

IP68-26: Incorporating PSMA PET/CT Parameters into Clinicopathologic Nomograms for Predicting Lymph Node Involvement in Intermediate- and High-Risk Prostate Cancer

Sunday, May 17, 2026 3:30 PM to 5:30 PM · 1 hr. 59 min. (America/New_York)

146A

Abstract

Sessions

IP68: Prostate Cancer: Localized: Surgical Therapy III

Sunday, May 17, 2026 3:30 PM to 5:30 PM

Log in

See all the content and easy-to-use features by logging in or registering!